2020
DOI: 10.1152/ajpendo.00368.2019
|View full text |Cite
|
Sign up to set email alerts
|

Interaction between accumulated 21-deoxysteroids and mineralocorticoid signaling in 21-hydroxylase deficiency

Abstract: 21-Hydroxylase deficiency (21OHD) is a rare genetic disorder in which salt-wasting syndrome occurs in 75% of cases, due to inability to synthesize cortisol and aldosterone. Recent mass spectrometry progress allowed identification of 21-deoxysteroids, i.e., 17-hydroxyprogesterone (17OHP), 21-deoxycortisol (21DF), and 21-deoxycorticosterone (21DB). We hypothesized that they may interfere with mineralocorticoid signaling and fludrocortisone therapy in patients with congenital adrenal hyperplasia (CAH) without eff… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 46 publications
0
6
0
Order By: Relevance
“…Different studies correlate prenatal exposure to androgens with these changes in the identity of affected individuals, determining a higher incidence of GD, in addition to direct disturbances on neurodevelopment or psychosocial development 6,7,14,15,16 . Mechanism that facilitates the determination of gender has not yet been fully elucidated.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Different studies correlate prenatal exposure to androgens with these changes in the identity of affected individuals, determining a higher incidence of GD, in addition to direct disturbances on neurodevelopment or psychosocial development 6,7,14,15,16 . Mechanism that facilitates the determination of gender has not yet been fully elucidated.…”
Section: Discussionmentioning
confidence: 99%
“…It is believed that, added to intrauterine fetal brain masculinization, a similar change occurs due to lack of adherence to glucocorticoid replacement therapy, during childhood and adolescence. In these patients, GD usually manifests itself in early adolescence 6,7 .…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations